Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
CreaVax-HCC by JW CreaGene for Hepatocellular Carcinoma: Likelihood of Approval
CreaVax-HCC is under clinical development by JW CreaGene and currently in Phase III for Hepatocellular Carcinoma. According to GlobalData, Phase...